Advertisement

Topics

Prana Company Profile

23:52 EDT 23rd June 2018 | BioPortfolio

Nil

Location

3275 Corporate View
Vista
California
92081
United States of America

Contact

Phone: 760.566.1070
Fax: 760.566.1071
Email: info@prana.com


News Articles [8 Associated News Articles listed on BioPortfolio]

Prana receives approval for Phase l trial of PBT434

Prana Biotechnology has received approval from the ethics committee to begin a Phase I clinical trial to investigate the safety,...Read More... The post Prana receives approval for Phase l trial of PB...

Prana Biotechnology (PRAN) Lifted to Hold at ValuEngine

Separately, B. Riley set a $4.00 target price on Prana Biotechnology and gave the company a buy rating in a research report on Friday, January 5th. Shares of PRAN stock traded up $0.07 on Wednesday, h...

Prana to initiate phase 1 trial of PBT434 to treat Parkinsonian diseases

Prana Biotechnology Ltd has received ethics committee approval and has commenced recruitment for its phase I clinical trial evaluating the safety, tolerability and pharmacokinetics of the company's le...

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

Prana Biotechnology (PRAN) PT Set at $4.00 by B. Riley

The brokerage presently has a "buy" rating on the biotechnology company's stock. B. Riley's target price would suggest a potential upside of 23.08% from the stock's current price.

Prana Biotechnology Ltd PBT Financial and Strategic SWOT Analysis Review [Report Updated: 09032018] Prices from USD $300

SummaryPrana Biotechnology Ltd Prana Biotech is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer, and other major agerela...

Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases

Highlights: Prana receives ethics committee approval for a clinical trial evaluating first in human dosing of PBT434 Recruitment has comm...

Prana Biotechnology Ltd PBT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14032018] Prices from USD $250

SummaryPrana Biotechnology Ltd Prana Biotech is a developer of therapeutic drugs. The company is conducting research into Huntington disease, Alzheimer's disease, brain cancer, and other major agerela...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

A randomized, exploratory molecular imaging study targeting amyloid β with a novel 8-OH quinoline in Alzheimer's disease: The PBT2-204 IMAGINE study.

We are developing a second generation 8-OH quinoline (2-(dimethylamino) methyl-5, 7-dichloro-8-hydroxyquinoline [PBT2, Prana Biotechnology]) for targeting amyloid β (Aβ) in Alzheimer's disease (AD)....

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...

Prana

Nil

Prana Biotechnology Ltd

More Information about "Prana" on BioPortfolio

We have published hundreds of Prana news stories on BioPortfolio along with dozens of Prana Clinical Trials and PubMed Articles about Prana for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Companies in our database. You can also find out about relevant Prana Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record